FDA Inspection 1168196 — Octapharma Plasma, Inc.
The FDA completed an inspection of Octapharma Plasma, Inc. on Apr 21, 2022 in Milwaukie, OR. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 21, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Milwaukie, OR (United States)